Eli Lilly and Company (NYSE: LLY) announced the completion of its acquisition of Centessa Pharmaceuticals plc (LSE: 0ACX), a clinical-stage ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE